MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Clinical and Pathological Features of CSF1R-Related Disorder Associated with the c.2330G>A, p.R777Q Pathogenic Variant

T. Chmiela, A. Strongosky, D. Dickson, Z. Wszolek (Katowice, Poland)

Meeting: 2025 International Congress

Keywords: Dementia, Frontotemporal dementias: Genetics, Parkinsonism

Category: Parkinsonism (Other)

Objective: To report the clinical and pathological features of CSF1R-RD associated with the c.2330G>A, p.R777Q variant, and to report a new family carrying this variant.

Background: Colony-stimulating factor-1 receptor (CSF1R)-related disorder (CSF1R-RD) is a rapidly progressive neurodegenerative disease with a median age of onset of 43 years. Most affected individuals develop rapidly progressive dementia and motor symptoms and eventually become bedridden; median disease duration is 6.8 years. More than 200 CSF1R pathogenic variants have been identified, but no genotype-phenotype correlation has been established. The c.2330G>A, p.R777Q variant has been reported previously as causative for CSF1R-RD; in silico analysis supports that this missense variant has a deleterious effect on protein structure/function

Method: We performed a literature search for CSF1R-RD associated with the c.2330G>A, p.R777Q variant and compared the collected data with data available from our new family.

Results: We identify 13 individuals from 8 families including ours affected by CSF1R-RD associated with the c.2330G>A, p.R777Q variant from Asia, Europe, and North America. The mean age of onset was 40.8±13.5 years (ranging from 22 to 63 years), and the mean survival was only 3.0±2.2 years. Brain autopsy of our index patient showed diffuse leukoencephalopathy with spheroids and pigmented glia, most severe in the frontal and parietal lobes; white matter was spared in the temporal and occipital lobes.

Conclusion: CSF1R-RD associated with the c.2330G>A, p.R777Q variant has a typical clinical and radiologic presentation of CSF1R-RD. Although the mean age of onset was close to that reported in the literature for all mutations, but it had a very wide range. In addition, the patients carrying this variant had a short survival, shorter than mean survival time for all mutations. Pathological abnormalities were like those observed on autopsies of other pathogenic variants.

References: Dulski K et al. CSF1R-related disorder: state of the art, challenges, and proposition of a new terminology. Parkinsonism Relat Disord. 2024;121:105894
Rademakers R, et al. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet. 2011 Dec 25;44(2):200-5.
Konno T et al. Clinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation. Eur J Neurol. 2017 Jan;24(1):37-45.
Dulski J et al. Global Presence and Penetrance of CSF1R-Related Disorder. Neurol Genet. 2024 Sep 13;10(5):e200187.
Papapetropoulos S et al. Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia: Review of Clinical Manifestations as Foundations for Therapeutic Development. Front Neurol. 2022 Feb 3;12:788168.
Papapetropoulos S et al. Clinical presentation and diagnosis of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: a literature analysis of case studies. Front Neurol. 2024 Mar 11;15:1320663
Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7(8):575-576
Hoffmann S, Murrell J, Harms L, et al. Enlarging the nosological spectrum of hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS). Brain Pathol. 2014;24(5):452-458

Makary MS, Awan U, Kisanuki YY, Slone HW. Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: Clinical and imaging characteristics. Neuroradiol J. 2019;32(2):139-142. doi:10.1177/1971400918822136
Tsai PC, Fuh JL, Yang CC, et al. Clinical and genetic characterization of adult-onset leukoencephalopathy caused by CSF1R mutations. Ann Clin Transl Neurol. 2021;8(11):2121-2131
Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 2001;11(5):863-874.
Guerreiro R, Kara E, Le Ber I, et al. Genetic analysis of inherited leukodystrophies: genotype-phenotype correlations in the CSF1R gene. JAMA Neurol. 2013;70(7):875-882
Inui T, Kawarai T, Fujita K, et al. A new CSF1R mutation presenting with an extensive white matter lesion mimicking primary progressive multiple sclerosis. J Neurol Sci. 2013;334(1-2):192-195.
Karle KN, Biskup S, Schüle R, et al. De novo mutations in hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS). Neurology. 2013;81(23):2039-2044
Chung B, Kim M, Kim SK, Kang H. A case of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia presenting with alien hand syndrome. eNeurologicalSci. 2022;30:100441

To cite this abstract in AMA style:

T. Chmiela, A. Strongosky, D. Dickson, Z. Wszolek. Clinical and Pathological Features of CSF1R-Related Disorder Associated with the c.2330G>A, p.R777Q Pathogenic Variant [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/clinical-and-pathological-features-of-csf1r-related-disorder-associated-with-the-c-2330ga-p-r777q-pathogenic-variant/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/clinical-and-pathological-features-of-csf1r-related-disorder-associated-with-the-c-2330ga-p-r777q-pathogenic-variant/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley